DK165730C - Sammensaetning til afgivelse af hydrofobe medikamenter og dennes fremstilling - Google Patents

Sammensaetning til afgivelse af hydrofobe medikamenter og dennes fremstilling

Info

Publication number
DK165730C
DK165730C DK438286A DK438286A DK165730C DK 165730 C DK165730 C DK 165730C DK 438286 A DK438286 A DK 438286A DK 438286 A DK438286 A DK 438286A DK 165730 C DK165730 C DK 165730C
Authority
DK
Denmark
Prior art keywords
delivery
preparation
composition
hydrophobic medicines
medicines
Prior art date
Application number
DK438286A
Other languages
English (en)
Other versions
DK438286D0 (da
DK165730B (da
DK438286A (da
Inventor
Narendra Raghunathji Desai
Madurai Ganesan
Eugene Albert Carpentier
Edward Charles Shinal
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of DK438286D0 publication Critical patent/DK438286D0/da
Publication of DK438286A publication Critical patent/DK438286A/da
Publication of DK165730B publication Critical patent/DK165730B/da
Application granted granted Critical
Publication of DK165730C publication Critical patent/DK165730C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK438286A 1985-09-16 1986-09-12 Sammensaetning til afgivelse af hydrofobe medikamenter og dennes fremstilling DK165730C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77630685 1985-09-16
US06/776,306 US4784845A (en) 1985-09-16 1985-09-16 Emulsion compostions for the parenteral administration of sparingly water soluble ionizable hydrophobic drugs

Publications (4)

Publication Number Publication Date
DK438286D0 DK438286D0 (da) 1986-09-12
DK438286A DK438286A (da) 1987-03-17
DK165730B DK165730B (da) 1993-01-11
DK165730C true DK165730C (da) 1993-06-07

Family

ID=25107019

Family Applications (1)

Application Number Title Priority Date Filing Date
DK438286A DK165730C (da) 1985-09-16 1986-09-12 Sammensaetning til afgivelse af hydrofobe medikamenter og dennes fremstilling

Country Status (18)

Country Link
US (1) US4784845A (da)
EP (1) EP0215313B1 (da)
JP (1) JPS6267018A (da)
KR (1) KR890004684B1 (da)
AR (1) AR242716A1 (da)
AT (1) ATE78683T1 (da)
AU (1) AU591705B2 (da)
CA (1) CA1272447A (da)
DE (1) DE3686221T2 (da)
DK (1) DK165730C (da)
ES (1) ES2002750A6 (da)
FI (1) FI863728L (da)
GR (1) GR862354B (da)
HU (1) HU199282B (da)
NO (1) NO863670L (da)
NZ (1) NZ217484A (da)
PH (1) PH23736A (da)
ZA (1) ZA867009B (da)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816247A (en) * 1985-09-11 1989-03-28 American Cyanamid Company Emulsion compositions for administration of sparingly water soluble ionizable hydrophobic drugs
US4820724A (en) * 1986-03-31 1989-04-11 University Of Southern California Dual phase solvent carrier system
GB8714652D0 (en) * 1987-06-23 1987-07-29 Davis S S Drug emulsion
US5229422A (en) * 1987-09-07 1993-07-20 Teijin Limited Extemporaneous preparation type kit of a pharmaceutical substance-containing fat emulsion
NZ227813A (en) * 1988-02-10 1990-03-27 Richardson Vicks Inc Oil in water emulsion having 3-40% oil and an amphipathic emulsifying agent in the range 0.02-2% and method of forming such emulsions
AU622664B2 (en) * 1988-03-21 1992-04-16 Daratech Pty Ltd Teat dip
NZ228431A (en) * 1988-03-21 1991-08-27 Daratech Pty Ltd Teat dip composition comprising a c16 to c20 fatty acid and a surfactant
CA1337397C (en) * 1988-09-29 1995-10-24 Hideo Nakajima Emulsified composition
US5364632A (en) * 1989-04-05 1994-11-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem Medicinal emulsions
US5004593A (en) * 1989-04-17 1991-04-02 Mayo Foundation For Medical Education And Research Hexamethylmelamine formulation exhibiting reduced neurotoxicity
JPH0832638B2 (ja) * 1989-05-25 1996-03-29 カイロン コーポレイション サブミクロン油滴乳剤を含んで成るアジュバント製剤
GB8919172D0 (en) * 1989-08-23 1989-10-04 Univ Nottingham Useful composition
EP0556392A4 (en) * 1990-11-06 1994-03-17 Nippon Shinyaku Co Ltd PROCESS FOR PRODUCING A FATTY EMULSION.
US5534502A (en) * 1990-11-06 1996-07-09 Nippon Shinyaku Co. Ltd. Process for producing fat emulsion
DE4124252A1 (de) * 1991-07-22 1993-01-28 Knoll Ag Verfahren zur herstellung einer sterilfiltrierbaren wirkstoffloesung
YU87892A (sh) * 1991-10-01 1995-12-04 Eli Lilly And Company Lilly Corporate Center Injektibilne formulacije produženog otpuštanja i postupci za njihovo dobijanje i primenu
IL103275A0 (en) * 1991-10-01 1993-02-21 Lilly Co Eli Injectable extended release formulations and methods
JPH06245700A (ja) * 1993-02-23 1994-09-06 Snow Brand Milk Prod Co Ltd 消化吸収性を低減した油脂組成物
WO1994028872A1 (en) * 1993-06-04 1994-12-22 Warner-Lambert Company Non-alcoholic cold and sinus medication
SE518823C2 (sv) * 1994-07-12 2002-11-26 Karlshamns Lipidteknik Ab Olja-i-vatten-emulsioner
CA2182575C (en) * 1994-02-04 2000-11-28 Anders Carlsson Oil-in-water emulsions
CA2182698A1 (en) * 1994-02-25 1995-08-31 Jun Sato Injectable emulsions containing antifungal triazole derivatives
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
ES2270426T3 (es) * 1994-03-18 2007-04-01 Supernus Pharmaceuticals, Inc. Sistema de suministros de farmacos emulsionados.
US5616330A (en) * 1994-07-19 1997-04-01 Hemagen/Pfc Stable oil-in-water emulsions incorporating a taxine (taxol) and method of making same
US5616342A (en) * 1995-04-11 1997-04-01 Pdt, Inc. Emulsioin suitable for administering a poorly water-soluble photosensitizing compound and use thereof
US5824638A (en) * 1995-05-22 1998-10-20 Shire Laboratories, Inc. Oral insulin delivery
DE69636706T2 (de) * 1995-09-25 2007-10-11 Ashmont Holdings Ltd., Takapuna Makrocyclische lacton anthelmintika
ATE252316T1 (de) 1996-06-05 2003-11-15 Ashmont Holdings Ltd Injizierbare zusammensetzungen
US6458373B1 (en) 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US6054421A (en) * 1997-09-23 2000-04-25 Scimed Life Systems, Inc. Medical emulsion lubricant
US6281175B1 (en) 1997-09-23 2001-08-28 Scimed Life Systems, Inc. Medical emulsion for lubrication and delivery of drugs
ID25533A (id) * 1997-09-30 2000-10-12 Lilly Co Eli Formulasi 2-metil-tieno-benzodiazepin
US6036946A (en) 1997-12-24 2000-03-14 Shaklee Corporation Methods for protecting skin from damaging effects of ultraviolet light
WO1999043301A1 (en) * 1998-02-24 1999-09-02 The Board Of Trustees Of The University Of Illinois Lipid emulsions in the treatment of systemic poisoning
US7030155B2 (en) * 1998-06-05 2006-04-18 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US6146664A (en) * 1998-07-10 2000-11-14 Shaklee Corporation Stable topical ascorbic acid compositions
US6682758B1 (en) 1998-12-22 2004-01-27 The United States Of America As Represented By The Department Of Health And Human Services Water-insoluble drug delivery system
US6777450B1 (en) * 2000-05-26 2004-08-17 Color Access, Inc. Water-thin emulsions with low emulsifier levels
MXPA04005260A (es) * 2001-12-03 2005-03-23 Novacea Inc Composiciones farmaceuticas que comprenden compuestos activos de vitamina d.
US20060078618A1 (en) * 2001-12-11 2006-04-13 Constantinides Panayiotis P Lipid particles and suspensions and uses thereof
US20040053895A1 (en) * 2002-09-18 2004-03-18 Bone Care International, Inc. Multi-use vessels for vitamin D formulations
US7148211B2 (en) * 2002-09-18 2006-12-12 Genzyme Corporation Formulation for lipophilic agents
US20040058895A1 (en) * 2002-09-18 2004-03-25 Bone Care International, Inc. Multi-use vessels for vitamin D formulations
US20040062779A1 (en) * 2002-09-26 2004-04-01 Jerry Whittemore Dermatologic composition using ultra-fine/micronized 1-ascorbic acid and other antioxidant ingredients in a stabilized anhydrous vehicle
US20060189586A1 (en) * 2003-06-11 2006-08-24 Cleland Jeffrey L Pharmaceutical compositions comprising active vitamin D compounds
US20050186230A1 (en) * 2004-01-23 2005-08-25 Sd Pharmaceuticals, Inc. Elemene compositions containing liquid oil
PL1838716T3 (pl) 2005-01-05 2011-09-30 Lilly Co Eli Dihydrat embonianu olanzapiny
WO2006106926A1 (ja) 2005-03-31 2006-10-12 Suntory Limited リグナン類化合物含有水中油滴型エマルション及びそれを含有する組成物
CN101547687A (zh) * 2005-11-17 2009-09-30 生物药效率有限公司 生物相容的潜在乳化剂
KR101425241B1 (ko) * 2006-10-04 2014-08-01 산토리 홀딩스 가부시키가이샤 리그난류 화합물 함유 ｏ/ｗ/ｏ형 에멀션 및 그것을 함유하는 조성물
WO2009042114A2 (en) 2007-09-21 2009-04-02 The Johns Hopkins University Phenazine derivatives and uses thereof
WO2010008891A2 (en) * 2008-06-24 2010-01-21 Merial Limited Anthelminthic formulations
CA2938626A1 (en) 2013-07-26 2015-01-29 John Rothman Compositions to improve the therapeutic benefit of bisantrene
EP3079668A1 (en) 2013-12-09 2016-10-19 Durect Corporation Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same
WO2018129345A1 (en) 2017-01-08 2018-07-12 Resq Pharma, Inc. Methods for decreasing injuries associated with intraoperative hypotension
US11389451B2 (en) * 2017-09-12 2022-07-19 Hyloris Developments S.A. Metolazone emulsion formulation
WO2020089942A2 (en) * 2018-11-02 2020-05-07 Amaterasu Lifesciences Llp A liquid injectable composition
WO2021026421A1 (en) * 2019-08-07 2021-02-11 Aclipse One Inc. Pharmaceutical compositions of (6as)-6-methyl-5,6,6a,7-tetrahydro-4h-dibenzo[de,g]quinoline-10,11-diol
WO2025182691A1 (ja) * 2024-02-29 2025-09-04 株式会社ユニファイジャパン ５－デアザフラビン化合物含有乳剤およびその製造方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3116203A (en) * 1962-03-14 1963-12-31 Hoffmann La Roche Oleaginous systems
US3172816A (en) * 1963-01-28 1965-03-09 Smith Kline French Lab Method of increasing the oil solubility of compounds and products thereof
US3647624A (en) * 1969-07-24 1972-03-07 Wisconsin Alumni Res Found Treatment of blood with oleaginous substance
US4124720A (en) * 1970-11-09 1978-11-07 Wenmaekers Georges E J Therapeutic hydrodispersible emulsion
US3996934A (en) * 1971-08-09 1976-12-14 Alza Corporation Medical bandage
FR2313078A1 (fr) * 1975-02-07 1976-12-31 Anvar Composition a base d'huile vegetale metabolisable et d'eau, utilisable notamment pour la constitution de preparations adjuvantes, ces preparations adjuvantes et leur procede d'obtention
DE2526938C2 (de) * 1975-02-14 1982-04-22 F. Hoffmann-La Roche & Co. AG, 4002 Basel Vitaminpräparate
US3991206A (en) * 1976-01-15 1976-11-09 American Cyanamid Company Alleviation of eye inflammation by topical application of p-biphenylacetic acid
US4168308A (en) * 1976-03-12 1979-09-18 Apoteksvarucentralen Vitrum Ab Composition for enhancing the administration of pharmacologically active agents
JPS5822085B2 (ja) * 1977-07-19 1983-05-06 株式会社ミドリ十字 静注用ガンマ・グロブリン製剤
ES484296A1 (es) * 1978-09-22 1980-10-01 Unilever Nv Un procedimiento de preparacion de una emulsion de agua en aceite adecuados para la preparacion de cosmeticos, farma- cos y otros productos.
US4340054A (en) * 1980-12-29 1982-07-20 Alza Corporation Dispenser for delivering fluids and solids
GB2105589B (en) * 1981-09-11 1985-10-23 Wellcome Found Injectable suspensions containing maleic acid or a salt thereof as a stabilising agent
JPS5859912A (ja) * 1981-10-06 1983-04-09 Green Cross Corp:The 鎮痛消炎物質脂肪乳剤
JPS59134710A (ja) * 1983-01-21 1984-08-02 Suntory Ltd 発酵養毛化粧料
US4563354A (en) * 1983-10-26 1986-01-07 Kabivitrum Ab Oil-in-water emulsion for parenteral administration
US4703062A (en) * 1984-01-16 1987-10-27 Baxter Travenol Laboratories, Inc. Parenteral nutrition with medium and long chain triglycerides
US4610868A (en) * 1984-03-20 1986-09-09 The Liposome Company, Inc. Lipid matrix carriers for use in drug delivery systems
JPH0647533B2 (ja) * 1984-08-10 1994-06-22 裕 水島 ４−ビフエニリル酢酸系化合物含有脂肪乳剤
US4707470A (en) * 1985-05-17 1987-11-17 Smithkline Beckman Corporation Polyene antibiotic emulsion formulation
US4816247A (en) * 1985-09-11 1989-03-28 American Cyanamid Company Emulsion compositions for administration of sparingly water soluble ionizable hydrophobic drugs

Also Published As

Publication number Publication date
NZ217484A (en) 1990-04-26
AU6269686A (en) 1987-03-19
KR890004684B1 (ko) 1989-11-25
HU199282B (en) 1990-02-28
JPS6267018A (ja) 1987-03-26
DK438286D0 (da) 1986-09-12
GR862354B (en) 1987-01-19
FI863728A7 (fi) 1987-03-17
DK165730B (da) 1993-01-11
NO863670L (no) 1987-03-17
DE3686221D1 (de) 1992-09-03
DK438286A (da) 1987-03-17
CA1272447A (en) 1990-08-07
US4784845A (en) 1988-11-15
PH23736A (en) 1989-11-03
EP0215313B1 (en) 1992-07-29
ATE78683T1 (de) 1992-08-15
KR870002835A (ko) 1987-04-13
EP0215313A2 (en) 1987-03-25
FI863728A0 (fi) 1986-09-15
NO863670D0 (no) 1986-09-15
AU591705B2 (en) 1989-12-14
ES2002750A6 (es) 1988-10-01
DE3686221T2 (de) 1993-02-25
ZA867009B (en) 1987-07-29
AR242716A1 (es) 1993-05-31
FI863728L (fi) 1987-03-17
EP0215313A3 (en) 1987-09-09
HUT43947A (en) 1988-01-28

Similar Documents

Publication Publication Date Title
DK165730C (da) Sammensaetning til afgivelse af hydrofobe medikamenter og dennes fremstilling
DK330287D0 (da) Antiinflammatorisk forbindelse og farmaceutisk sammensaetning indeholdende samme
DK546886D0 (da) Farmaceutisk praeparat
DK481585A (da) Farmaceutisk praeparat indeholdende anthracyclinglycosider
DK51493D0 (da) Laegemiddel indeholdende humant interleukin-1alfa og anvendelse af interleukin-1alfa til fremstilling af et saadant laegemiddel
DK263288D0 (da) Farmaceutisk praeparat af cefuroxim-axetil
DK195988A (da) Farmaceutisk praeparat indeholdende mikrokapsler
BR1100036A (pt) Composto e composição farmacêutica
DK237187A (da) Farmaceutisk anvendelse af t-pa
IT1214683B (it) Composizioni farmaceutiche nasali
DK537685A (da) Fremgangsmaade til fremstilling af isosilybinfrit silibinin samt laegemiddel med indhold deraf
DK280282A (da) Fremgangsmaade til fremstilling af farmaceutiske praeparater indeholdende ergotalkaloider
DK288686D0 (da) Farmaceutiske praeparater
DK52086D0 (da) Farmaceutiske praeparater indeholdende ergotalkaloider
DK0458855T3 (da) Farmaceutisk præparat til behandling af tonsillitis
IT1197811B (it) 2h-benzotriazoli 5-superiore alchil-sostituiti e composizioni stabilizzate
DK560989A (da) Anvendelse af ethylendiamintetraeddikesyre til fremstilling af laegemidler
DK701588A (da) N-hydroxy-5-phenyl-2-furancarboximidamider og anvendelse heraf til fremstilling af farmceutiske praeparater
IT1200467B (it) Formulazione farmaceutica
IT1203737B (it) Composizioni farmaceutiche comprendenti 3-amminopropossi-indoli
DK302887A (da) Anvendelse af tumornecrosefaktor-alfa til fremstilling af antiinfektivt laegemiddel
NL185666C (nl) Farmaceutisch preparaat of voorwerp en geneeskrachtige verbindingen.
DK151785D0 (da) 3-aminoalkylthio-1-phenylindolforbindelser og farmaceutiske praeparater
DK68790D0 (da) Anvendelse af tripeptidet l-pyroglutamyl-l-histidylglycin til fremstilling af laegemidler
DK489186A (da) Fremgangsmaade til fremstilling af amidinourinstoffer og farmaceutisk praeparat

Legal Events

Date Code Title Description
PBP Patent lapsed